{"organizations": ["Cipla"], "uuid": "30883fac5e77332e5d4785b75257360d977b64bd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Cipla-to-acquire-100-25-of-generic-businesses-in-US-for--24550M-48014-1/", "country": "US", "title": "Cipla to acquire 100% of generic businesses in US for $550M", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Cipla to acquire 100% of generic businesses in US for $550M", "spam_score": 0.0, "site_type": "news", "published": "2015-09-03T18:50:00.000+03:00", "replies_count": 0, "uuid": "30883fac5e77332e5d4785b75257360d977b64bd"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Cipla-to-acquire-100-25-of-generic-businesses-in-US-for--24550M-48014-1/", "ord_in_thread": 0, "title": "Cipla to acquire 100% of generic businesses in US for $550M", "locations": ["US"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " ", "external_links": [], "published": "2015-09-03T18:50:00.000+03:00", "crawled": "2015-09-04T09:57:56.117+03:00", "highlightTitle": ""}